About Shivalik Rasayan Limited
Data last updated: 14 July 2026
Shivalik Rasayan Limited is a public limited company based in Dehradun, Uttarakhand, India, a subsidiary of Growel Remedies Limited. It specialises in crop protection, a part of the broader agriculture sector. Incorporated on 16 March 1979, the company has been in operation for over 47 years.
Registered with ROC Uttarakhand under CIN L24237UR1979PLC005041. Listed on BSE: 539148 and NSE: SHIVALIK.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.88 Cr. Formerly known as Shivalik Rasayan Udyog Limited. It is led by directors including Sangeeta Bishnoi and Sumita Dwivedi.
Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Village Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹368 Cr, a growth of 18.04% compared to the previous year. The net worth stands at ₹599.1 Cr (up 11.78% YoY). Total assets are valued at ₹818.87 Cr (up 11.56% YoY).
It operates as a subsidiary of Growel Remedies Limited.
The company is associated with 2 brands - Shivalik Rasayan, Shivalik Rasayan Limited. As per MCA filings, the company has open charges of ₹125.2 Cr and satisfied charges of ₹21.54 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivalikrasayan.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressVillage Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007
-
IndustryAgriculture, Crop Protection
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Shivalik Rasayan Limited
Shivalik Rasayan Limited operates two associated brands: Shivalik Rasayan and Shivalik Rasayan Limited. These brands represent Shivalik Rasayan Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Organophosphorus insecticides are manufactured and supplied for agriculture. | shivalikrasayan.in | |
| Shivalik Rasayan Limited is engaged in manufacturing APIs and agrochemicals. | shivalikrasayan.com |
Competitors & Alternatives of Shivalik Rasayan Limited
Brands and companies operating in the same space as Shivalik Rasayan Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
|
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
|
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
|
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
|
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
|
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
|
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
|
|
Generic formulations including tablets, capsules, liquids, and injectables are manufactured. | Shenzhen, China, China | 1992 |
|
|
Provider of drug research & development services for multiple therapeutic areas | Boston, United States, United States | 2021 |
Business Activity of Shivalik Rasayan Limited
Shivalik Rasayan Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Shivalik Rasayan Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Shivalik Rasayan Limited
Shivalik Rasayan Limited is audited by M/s Rahul Chaudhary & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2026-09-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s Rahul Chaudhary & Associates, Chartered Accountants (ICAI peer reviewed, certificate valid till 2026-09-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Shivalik Rasayan Limited
Shivalik Rasayan Limited is currently managed by 10 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sangeeta Bishnoi
Also directs:
Medicamen Biotech Limited
|
Director | 11 Feb 2019 | 7 Years 6 Months | Current |
|
Sumita Dwivedi
Also directs:
Medicamen Biotech Limited, Skyforge System Solutions Llp
|
Director | 13 Nov 2018 | 7 Years 9 Months | Current |
|
Ravi Kumar Bansal
Also directs:
Medicamen Biotech Limited
|
Director | 14 Aug 2019 | 7 Years 0 Months | Current |
| Rahul Bishnoi | Director | 23 Feb 2002 | 24 Years 6 Months | Current |
| Ashwani Kumar Sharma | Director | 18 Jul 2003 | 23 Years 1 Months | Current |
|
Vimal Kumar Shrawat
Also directs:
Medicamen Biotech Limited, Chem Pharma Healthcare Private Limited
|
Managing Director | 17 Nov 2018 | 7 Years 9 Months | Current |
Financials of Shivalik Rasayan Limited FY 2026 filings available
Shivalik Rasayan Limited reported revenue of ₹368 Cr (up 18.04% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹368 Cr | ₹311.77 Cr | ₹272.98 Cr | ₹234.45 Cr | ₹214.75 Cr |
| Other Income | ₹4.08 Cr | ₹8.31 Cr | ₹3.98 Cr | ₹4.66 Cr | ₹3.71 Cr |
| Total Income | ₹372.08 Cr | ₹320.08 Cr | ₹276.96 Cr | ₹239.11 Cr | ₹218.46 Cr |
| Cost of Materials Consumed | ₹196.99 Cr | ₹173.45 Cr | ₹156.08 Cr | ₹132.66 Cr | ₹101.92 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹8.62 Cr | -₹13.04 Cr | -₹16.23 Cr | -₹17.94 Cr | -₹7.81 Cr |
| Employee Benefit Expense | ₹60.55 Cr | ₹55.02 Cr | ₹46.82 Cr | ₹36.94 Cr | ₹29.82 Cr |
| Finance Costs | ₹9.6 Cr | ₹9.33 Cr | ₹7.63 Cr | ₹4.34 Cr | ₹2.5 Cr |
| Depreciation & Amortisation | ₹18.77 Cr | ₹15.77 Cr | ₹12.38 Cr | ₹11.6 Cr | ₹11.01 Cr |
| Other Expenses | ₹73.31 Cr | ₹56.14 Cr | ₹47.14 Cr | ₹39.85 Cr | ₹44.06 Cr |
| Total Expenses | ₹350.61 Cr | ₹296.67 Cr | ₹253.81 Cr | ₹207.45 Cr | ₹181.5 Cr |
| Profit Before Exceptional Items & Tax | ₹21.48 Cr | ₹23.41 Cr | ₹23.15 Cr | ₹31.66 Cr | ₹36.96 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹21.48 Cr | ₹23.41 Cr | ₹23.15 Cr | ₹31.66 Cr | ₹36.96 Cr |
| Total Tax Expense | ₹3.51 Cr | ₹2.98 Cr | ₹5.08 Cr | ₹1.83 Cr | ₹2.7 Cr |
| Net Profit | ₹17.97 Cr | ₹20.42 Cr | ₹18.07 Cr | ₹29.83 Cr | ₹34.25 Cr |
| attributable to Owners | ₹12.14 Cr | ₹16.69 Cr | ₹16.36 Cr | - | ₹0 |
| attributable to NCI | ₹5.83 Cr | ₹3.73 Cr | ₹1.71 Cr | - | ₹0 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹17.97 Cr | ₹20.42 Cr | ₹18.07 Cr | ₹29.83 Cr | ₹34.25 Cr |
| EBITDA (computed) | ₹49.84 Cr | ₹48.51 Cr | ₹43.16 Cr | ₹47.61 Cr | ₹50.46 Cr |
| Basic EPS | ₹7.71 | ₹10.60 | ₹10.75 | ₹15.02 | ₹18.12 |
| Diluted EPS | ₹7.71 | ₹10.60 | ₹10.75 | ₹15.02 | ₹18.12 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹818.87 Cr | ₹734.02 Cr | ₹692.47 Cr | ₹578.24 Cr |
| Non-current Assets | ₹436.79 Cr | ₹416.64 Cr | ₹398.56 Cr | ₹316.69 Cr |
| Current Assets | ₹382.08 Cr | ₹317.39 Cr | ₹293.91 Cr | ₹261.56 Cr |
| Property, Plant & Equipment | ₹334 Cr | ₹335.66 Cr | ₹213.11 Cr | ₹217.29 Cr |
| Inventories | ₹146.87 Cr | ₹117.7 Cr | ₹101.83 Cr | ₹74.99 Cr |
| Trade Receivables | ₹115.14 Cr | ₹96.12 Cr | ₹86.74 Cr | ₹84.77 Cr |
| Cash & Equivalents | ₹34.37 Cr | ₹27.97 Cr | ₹37.74 Cr | ₹30.67 Cr |
| Equity (Net Worth) | ₹599.1 Cr | ₹535.96 Cr | ₹507.57 Cr | ₹419.28 Cr |
| Equity Share Capital | ₹7.88 Cr | ₹7.88 Cr | ₹7.78 Cr | ₹7.24 Cr |
| Borrowings (Non-current) | ₹26.18 Cr | ₹16.5 Cr | ₹23.97 Cr | ₹13.01 Cr |
| Borrowings (Current) | ₹87.46 Cr | ₹77.38 Cr | ₹52.11 Cr | ₹44.7 Cr |
| Total Debt (computed) | ₹113.64 Cr | ₹93.88 Cr | ₹76.08 Cr | ₹57.71 Cr |
| Current Liabilities | ₹190.18 Cr | ₹178.2 Cr | ₹158.44 Cr | ₹143.56 Cr |
| Total Liabilities | ₹219.76 Cr | ₹198.06 Cr | ₹184.9 Cr | ₹158.96 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹33.96 Cr | -₹7.58 Cr | -₹6.36 Cr | -₹18.95 Cr | ₹9.89 Cr |
| Investing Cash Flow | -₹21.23 Cr | -₹12.52 Cr | -₹85.81 Cr | -₹70.77 Cr | -₹23.36 Cr |
| Financing Cash Flow | ₹61.58 Cr | ₹10.33 Cr | ₹99.24 Cr | ₹49.63 Cr | ₹79.45 Cr |
| Capital Expenditure | ₹23.32 Cr | ₹20.83 Cr | ₹79.16 Cr | ₹63.23 Cr | ₹24.97 Cr |
| Free Cash Flow (computed) | -₹57.28 Cr | -₹28.41 Cr | -₹85.52 Cr | -₹82.18 Cr | -₹15.08 Cr |
| Dividends Paid | ₹2.14 Cr | ₹2.05 Cr | ₹2.01 Cr | ₹72.44 Lakh | ₹68.9 Lakh |
| Net Change in Cash | ₹6.4 Cr | -₹9.77 Cr | ₹7.07 Cr | -₹40.09 Cr | ₹70.76 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹102.82 Cr | ₹82.04 Cr | ₹93.84 Cr | ₹89.31 Cr | ₹69.39 Cr | ₹85.31 Cr | ₹82.44 Cr | ₹74.63 Cr | ₹71.23 Cr | ₹70.23 Cr | ₹67.05 Cr | ₹64.47 Cr |
| Other Income | ₹1.92 Cr | ₹1.18 Cr | ₹38.84 Lakh | ₹59.71 Lakh | ₹5.71 Cr | ₹1.6 Cr | ₹35.43 Lakh | ₹63.82 Lakh | ₹1.49 Cr | ₹1.5 Cr | ₹56.13 Lakh | ₹42.22 Lakh |
| Total Income | ₹104.73 Cr | ₹83.21 Cr | ₹94.23 Cr | ₹89.91 Cr | ₹75.1 Cr | ₹86.91 Cr | ₹82.8 Cr | ₹75.27 Cr | ₹72.73 Cr | ₹71.74 Cr | ₹67.61 Cr | ₹64.89 Cr |
| Cost of Materials Consumed | ₹49.17 Cr | ₹49.17 Cr | ₹53.29 Cr | ₹45.36 Cr | ₹28.97 Cr | ₹54.25 Cr | ₹52.34 Cr | ₹37.88 Cr | ₹38.62 Cr | ₹39.17 Cr | ₹39.67 Cr | ₹38.62 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹6.34 Cr | -₹11.07 Cr | -₹6.36 Cr | ₹2.47 Cr | ₹3.83 Cr | -₹11.51 Cr | -₹8.98 Cr | ₹3.63 Cr | -₹1.76 Cr | -₹2.8 Cr | -₹5.12 Cr | -₹6.55 Cr |
| Employee Benefit Expense | ₹15.64 Cr | ₹15.24 Cr | ₹15.66 Cr | ₹14.01 Cr | ₹14.83 Cr | ₹13.92 Cr | ₹13.98 Cr | ₹12.3 Cr | ₹12.8 Cr | ₹12.69 Cr | ₹11.13 Cr | ₹10.2 Cr |
| Finance Costs | ₹2.46 Cr | ₹2.31 Cr | ₹2.22 Cr | ₹2.62 Cr | ₹2.71 Cr | ₹2.26 Cr | ₹2.45 Cr | ₹1.92 Cr | ₹2.61 Cr | ₹1.58 Cr | ₹1.96 Cr | ₹1.47 Cr |
| Depreciation & Amortisation | ₹4.16 Cr | ₹5.06 Cr | ₹4.73 Cr | ₹4.82 Cr | ₹2.78 Cr | ₹4.84 Cr | ₹4.66 Cr | ₹3.5 Cr | ₹3.11 Cr | ₹3.01 Cr | ₹3.44 Cr | ₹2.81 Cr |
| Other Expenses | ₹19.24 Cr | ₹18.37 Cr | ₹19.21 Cr | ₹16.49 Cr | ₹16 Cr | ₹15.34 Cr | ₹13.35 Cr | ₹11.44 Cr | ₹12.29 Cr | ₹12.31 Cr | ₹11.7 Cr | ₹10.84 Cr |
| Total Expenses | ₹97.01 Cr | ₹79.09 Cr | ₹88.75 Cr | ₹85.76 Cr | ₹69.13 Cr | ₹79.09 Cr | ₹77.79 Cr | ₹70.66 Cr | ₹67.67 Cr | ₹65.96 Cr | ₹62.8 Cr | ₹57.38 Cr |
| Profit Before Exceptional Items & Tax | ₹7.73 Cr | ₹4.13 Cr | ₹5.48 Cr | ₹4.15 Cr | ₹5.98 Cr | ₹7.82 Cr | ₹5.01 Cr | ₹4.6 Cr | ₹5.06 Cr | ₹5.77 Cr | ₹4.81 Cr | ₹7.51 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹7.73 Cr | ₹4.13 Cr | ₹5.48 Cr | ₹4.15 Cr | ₹5.98 Cr | ₹7.82 Cr | ₹5.01 Cr | ₹4.6 Cr | ₹5.06 Cr | ₹5.77 Cr | ₹4.81 Cr | ₹7.51 Cr |
| Total Tax Expense | ₹55.31 Lakh | ₹45.72 Lakh | ₹1.17 Cr | ₹1.33 Cr | ₹78.55 Lakh | ₹88.23 Lakh | ₹58.04 Lakh | ₹73.66 Lakh | ₹45.58 Lakh | ₹1.43 Cr | ₹2.17 Cr | ₹1.03 Cr |
| Net Profit | ₹7.17 Cr | ₹3.67 Cr | ₹4.3 Cr | ₹2.82 Cr | ₹5.19 Cr | ₹6.94 Cr | ₹4.43 Cr | ₹3.87 Cr | ₹4.6 Cr | ₹4.34 Cr | ₹2.65 Cr | ₹6.48 Cr |
| attributable to Owners | ₹4.53 Cr | ₹2.7 Cr | ₹3.05 Cr | ₹1.6 Cr | ₹4.13 Cr | - | ₹4.01 Cr | ₹3.52 Cr | ₹3.44 Cr | ₹3.06 Cr | ₹1.88 Cr | - |
| attributable to NCI | ₹2.65 Cr | ₹97.33 Lakh | ₹1.26 Cr | ₹1.22 Cr | ₹1.06 Cr | - | ₹41.75 Lakh | ₹34.34 Lakh | ₹1.16 Cr | ₹1.28 Cr | ₹76.61 Lakh | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹7.17 Cr | ₹3.67 Cr | ₹4.3 Cr | ₹2.82 Cr | ₹5.19 Cr | ₹6.94 Cr | ₹4.43 Cr | ₹3.87 Cr | ₹4.6 Cr | ₹4.34 Cr | ₹2.65 Cr | ₹6.48 Cr |
| EBITDA (computed) | ₹14.34 Cr | ₹11.5 Cr | ₹12.42 Cr | ₹11.58 Cr | ₹11.47 Cr | ₹14.91 Cr | ₹12.11 Cr | ₹10.02 Cr | ₹10.78 Cr | ₹10.37 Cr | ₹10.22 Cr | ₹11.79 Cr |
| Basic EPS | ₹2.87 | ₹1.71 | ₹1.93 | ₹1.02 | ₹2.62 | ₹3.39 | ₹2.58 | ₹2.27 | ₹2.26 | ₹2.03 | ₹1.26 | ₹2.28 |
| Diluted EPS | ₹2.87 | ₹1.71 | ₹1.93 | ₹1.02 | ₹2.62 | ₹3.39 | ₹2.58 | ₹2.27 | ₹2.26 | ₹2.03 | ₹1.26 | ₹2.28 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agrochemicals | ₹34.44 Cr | ₹2.68 Cr | ₹317.12 Cr | ₹59.78 Cr |
| Active Pharma Ingredient (API) | ₹4.74 Cr | ₹2.06 Cr | ₹125.69 Cr | ₹12.1 Cr |
| Pharma Formulation | ₹60.65 Cr | ₹5.44 Cr | ₹356.09 Cr | ₹48.47 Cr |
| Unallacated other operating revenue | ₹2.99 Cr | ₹0 | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agrochemicals | ₹151.26 Cr | ₹22.02 Cr | - | - |
| Active Pharma Ingredient (API) | ₹9.05 Cr | -₹6.43 Cr | - | - |
| Pharma Formulation | ₹197.77 Cr | ₹15.48 Cr | - | - |
| Unallacated other operating revenue | ₹9.93 Cr | ₹0 | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹170.23 Cr | ₹149.23 Cr | ₹93.68 Cr | ₹93.58 Cr |
| Other Income | ₹96.45 Lakh | ₹2.06 Cr | ₹1.65 Cr | ₹2.2 Cr |
| Total Income | ₹171.2 Cr | ₹151.29 Cr | ₹95.33 Cr | ₹95.78 Cr |
| Cost of Materials Consumed | ₹102.65 Cr | ₹82.8 Cr | ₹51.38 Cr | ₹50.85 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹16.04 Cr | -₹7.01 Cr | -₹4.13 Cr | -₹8.23 Cr |
| Employee Benefit Expense | ₹25.86 Cr | ₹23.15 Cr | ₹16.75 Cr | ₹16.49 Cr |
| Finance Costs | ₹6.1 Cr | ₹6.18 Cr | ₹3.23 Cr | ₹1.42 Cr |
| Depreciation & Amortisation | ₹11.55 Cr | ₹8.7 Cr | ₹5.28 Cr | ₹5.24 Cr |
| Other Expenses | ₹31.59 Cr | ₹23.94 Cr | ₹12.74 Cr | ₹15.39 Cr |
| Total Expenses | ₹161.71 Cr | ₹137.76 Cr | ₹85.25 Cr | ₹81.16 Cr |
| Profit Before Exceptional Items & Tax | ₹9.49 Cr | ₹13.53 Cr | ₹10.08 Cr | ₹14.62 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹9.49 Cr | ₹13.53 Cr | ₹10.08 Cr | ₹14.62 Cr |
| Total Tax Expense | ₹1.32 Cr | -₹33.95 Lakh | ₹1.5 Cr | -₹48.77 Lakh |
| Net Profit | ₹8.17 Cr | ₹13.87 Cr | ₹8.58 Cr | ₹15.1 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹8.17 Cr | ₹13.87 Cr | ₹8.58 Cr | ₹15.1 Cr |
| EBITDA (computed) | ₹27.14 Cr | ₹28.41 Cr | ₹18.59 Cr | ₹21.27 Cr |
| Basic EPS | ₹5.19 | ₹8.80 | ₹5.63 | ₹10.42 |
| Diluted EPS | ₹5.19 | ₹8.80 | ₹5.63 | ₹10.42 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹527.97 Cr | ₹511.61 Cr | ₹471.37 Cr | ₹364.67 Cr |
| Non-current Assets | ₹369.62 Cr | ₹358.77 Cr | ₹332.74 Cr | ₹260.8 Cr |
| Current Assets | ₹158.35 Cr | ₹152.84 Cr | ₹138.63 Cr | ₹103.87 Cr |
| Property, Plant & Equipment | ₹249.91 Cr | ₹249.54 Cr | ₹122.16 Cr | ₹125.53 Cr |
| Inventories | ₹76.79 Cr | ₹55.56 Cr | ₹42.45 Cr | ₹29.93 Cr |
| Trade Receivables | ₹33.31 Cr | ₹27.22 Cr | ₹31.48 Cr | ₹19.52 Cr |
| Cash & Equivalents | ₹3.1 Cr | ₹24.21 Cr | ₹22.95 Cr | ₹9.89 Cr |
| Equity (Net Worth) | ₹404.65 Cr | ₹397.65 Cr | ₹374.04 Cr | ₹290.81 Cr |
| Equity Share Capital | ₹7.88 Cr | ₹7.88 Cr | ₹7.78 Cr | ₹7.24 Cr |
| Borrowings (Non-current) | ₹20.03 Cr | ₹12.77 Cr | ₹22.71 Cr | ₹12.14 Cr |
| Borrowings (Current) | ₹45.83 Cr | ₹47.86 Cr | ₹22.55 Cr | ₹21.39 Cr |
| Total Debt (computed) | ₹65.86 Cr | ₹60.63 Cr | ₹45.26 Cr | ₹33.53 Cr |
| Current Liabilities | ₹102.26 Cr | ₹100.04 Cr | ₹73.88 Cr | ₹60.99 Cr |
| Total Liabilities | ₹123.33 Cr | ₹113.96 Cr | ₹97.33 Cr | ₹73.86 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | -₹1.26 Cr | -₹1.04 Cr | ₹47.2 Lakh | -₹12.66 Cr |
| Investing Cash Flow | -₹18.19 Cr | -₹19.71 Cr | -₹80.25 Cr | -₹64.89 Cr |
| Financing Cash Flow | -₹1.66 Cr | ₹22.01 Cr | ₹92.84 Cr | ₹20.51 Cr |
| Capital Expenditure | ₹18.54 Cr | ₹20.74 Cr | ₹72.87 Cr | ₹56.63 Cr |
| Free Cash Flow (computed) | -₹19.8 Cr | -₹21.78 Cr | -₹72.4 Cr | -₹69.29 Cr |
| Dividends Paid | ₹78.75 Lakh | ₹77.8 Lakh | ₹74.55 Lakh | ₹72.44 Lakh |
| Net Change in Cash | -₹21.11 Cr | ₹1.26 Cr | ₹13.06 Cr | -₹57.04 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹42.17 Cr | ₹35.13 Cr | ₹46.67 Cr | ₹46.26 Cr | ₹39.78 Cr | ₹40.16 Cr | ₹37.7 Cr | ₹31.58 Cr | ₹23.92 Cr | ₹23.73 Cr | ₹23.51 Cr | ₹22.52 Cr |
| Other Income | ₹18.12 Lakh | ₹64.09 Lakh | ₹1.56 Lakh | ₹12.68 Lakh | ₹48.29 Lakh | ₹1.46 Cr | ₹6.47 Lakh | ₹5.19 Lakh | ₹92.59 Lakh | ₹67.11 Lakh | ₹1.15 Lakh | ₹4.3 Lakh |
| Total Income | ₹42.35 Cr | ₹35.77 Cr | ₹46.69 Cr | ₹46.39 Cr | ₹40.26 Cr | ₹41.63 Cr | ₹37.76 Cr | ₹31.63 Cr | ₹24.84 Cr | ₹24.4 Cr | ₹23.52 Cr | ₹22.57 Cr |
| Cost of Materials Consumed | ₹23.08 Cr | ₹27.48 Cr | ₹31.32 Cr | ₹20.76 Cr | ₹17.45 Cr | ₹25.73 Cr | ₹23.4 Cr | ₹16.22 Cr | ₹16.79 Cr | ₹10.07 Cr | ₹12.01 Cr | ₹12.51 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹23.25 Lakh | -₹13.09 Cr | -₹7.55 Cr | ₹4.36 Cr | ₹1.58 Cr | -₹5.31 Cr | -₹4.48 Cr | ₹1.2 Cr | -₹3.54 Cr | ₹1.32 Cr | -₹60.22 Lakh | -₹1.31 Cr |
| Employee Benefit Expense | ₹6.24 Cr | ₹6.87 Cr | ₹6.83 Cr | ₹5.92 Cr | ₹6.43 Cr | ₹5.91 Cr | ₹6.34 Cr | ₹4.46 Cr | ₹4.41 Cr | ₹4.68 Cr | ₹4.03 Cr | ₹3.63 Cr |
| Finance Costs | ₹2.07 Cr | ₹1.34 Cr | ₹1.23 Cr | ₹1.46 Cr | ₹2.06 Cr | ₹1.5 Cr | ₹1.41 Cr | ₹1.21 Cr | ₹72.36 Lakh | ₹93.41 Lakh | ₹1.06 Cr | ₹51.63 Lakh |
| Depreciation & Amortisation | ₹2.43 Cr | ₹3.24 Cr | ₹2.87 Cr | ₹3.01 Cr | ₹2.3 Cr | ₹2.63 Cr | ₹2.05 Cr | ₹1.72 Cr | ₹1.34 Cr | ₹1.21 Cr | ₹1.62 Cr | ₹1.12 Cr |
| Other Expenses | ₹5.63 Cr | ₹7.92 Cr | ₹9.18 Cr | ₹8.86 Cr | ₹6.95 Cr | ₹7.23 Cr | ₹5.99 Cr | ₹3.77 Cr | ₹2.71 Cr | ₹3.7 Cr | ₹3.06 Cr | ₹3.27 Cr |
| Total Expenses | ₹39.68 Cr | ₹33.75 Cr | ₹43.89 Cr | ₹44.38 Cr | ₹36.78 Cr | ₹37.68 Cr | ₹34.71 Cr | ₹28.58 Cr | ₹22.44 Cr | ₹21.9 Cr | ₹21.17 Cr | ₹19.74 Cr |
| Profit Before Exceptional Items & Tax | ₹2.67 Cr | ₹2.02 Cr | ₹2.79 Cr | ₹2.02 Cr | ₹3.49 Cr | ₹3.94 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹2.4 Cr | ₹2.5 Cr | ₹2.35 Cr | ₹2.82 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.67 Cr | ₹2.02 Cr | ₹2.79 Cr | ₹2.02 Cr | ₹3.49 Cr | ₹3.94 Cr | ₹3.05 Cr | ₹3.05 Cr | ₹2.4 Cr | ₹2.5 Cr | ₹2.35 Cr | ₹2.82 Cr |
| Total Tax Expense | -₹5.96 Lakh | -₹1.91 Lakh | ₹60.29 Lakh | ₹79.46 Lakh | ₹15.88 Lakh | -₹7.26 Lakh | -₹40.45 Lakh | -₹2.11 Lakh | -₹15.94 Lakh | ₹18.89 Lakh | ₹1.18 Cr | ₹29.03 Lakh |
| Net Profit | ₹2.73 Cr | ₹2.03 Cr | ₹2.19 Cr | ₹1.22 Cr | ₹3.33 Cr | ₹4.02 Cr | ₹3.45 Cr | ₹3.07 Cr | ₹2.56 Cr | ₹2.31 Cr | ₹1.17 Cr | ₹2.53 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹2.73 Cr | ₹2.03 Cr | ₹2.19 Cr | ₹1.22 Cr | ₹3.33 Cr | ₹4.02 Cr | ₹3.45 Cr | ₹3.07 Cr | ₹2.56 Cr | ₹2.31 Cr | ₹1.17 Cr | ₹2.53 Cr |
| EBITDA (computed) | ₹7.17 Cr | ₹6.59 Cr | ₹6.89 Cr | ₹6.49 Cr | ₹7.85 Cr | ₹8.06 Cr | ₹6.51 Cr | ₹5.99 Cr | ₹4.46 Cr | ₹4.64 Cr | ₹5.03 Cr | ₹4.46 Cr |
| Basic EPS | ₹1.73 | ₹1.29 | ₹1.39 | ₹0.78 | ₹2.11 | ₹2.58 | ₹2.22 | ₹1.97 | ₹1.68 | ₹1.55 | ₹0.79 | ₹1.75 |
| Diluted EPS | ₹1.73 | ₹1.29 | ₹1.39 | ₹0.78 | ₹2.11 | ₹2.58 | ₹2.22 | ₹1.97 | ₹1.68 | ₹1.55 | ₹0.79 | ₹1.75 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agrochemicals | ₹34.44 Cr | ₹2.68 Cr | ₹317.12 Cr | ₹59.78 Cr |
| Active Pharma Ingredient (API) | ₹4.74 Cr | ₹2.06 Cr | ₹125.69 Cr | ₹12.1 Cr |
| Pharma Formulation | ₹0 | ₹0 | ₹0 | ₹0 |
| Unallacated other operating revenue | ₹2.99 Cr | ₹0 | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agrochemicals | ₹151.26 Cr | ₹22.02 Cr | - | - |
| Active Pharma Ingredient (API) | ₹9.05 Cr | -₹6.43 Cr | - | - |
| Pharma Formulation | ₹0 | ₹0 | - | - |
| Unallacated other operating revenue | ₹9.93 Cr | ₹0 | - | - |
Shareholding Pattern of Shivalik Rasayan Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 47.37%, foreign institutional investors hold 4.20%, retail and other public shareholders hold 48.42% of Shivalik Rasayan Limited. The company had 13,413 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 47.37% | 47.37% | 47.37% | 47.37% | 47.37% | 47.95% |
| Public | 52.63% | 52.63% | 52.63% | 52.63% | 52.63% | 52.05% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|---|---|
| Promoters | 47.37% | 47.37% | 47.95% | 50.32% | 50.32% |
| Public | 52.63% | 52.63% | 52.05% | 49.68% | 49.68% |
| Promoter change (YoY, %pts) | +0.00 | -0.58 | -2.37 | +0.00 | - |
Board & Governance of Shivalik Rasayan Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Shivalik Rasayan Limited has 11 directors - 6 independent and 3 executive. The board is chaired by Rahul Bishnoi.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Sanjay Bansal | Non-Executive - Non Independent Director | 2018-03-05 | 2 |
| Rahul Bishnoi | Executive Director · Chairperson | 2002-02-23 | 2 |
| Suresh Kumar Singh | Executive Director | 1997-12-15 | 2 |
| Ashwani Kumar Sharma | Non-Executive - Non Independent Director | 2003-07-18 | 2 |
| Vimal Kumar Shrawat | Executive Director · MD | 2018-11-17 | 2 |
| Sumita Dwivedi | Non-Executive - Independent Director | 2018-11-13 | 2 |
| Sangeeta Bishnoi | Non-Executive - Independent Director | 2019-02-11 | 2 |
| Ravi Kumar Bansal | Non-Executive - Independent Director | 2019-08-14 | 2 |
| Ramit Madan | Non-Executive - Independent Director | 2024-08-13 | 1 |
| Shaival Saurabh | Non-Executive - Independent Director | 2024-08-13 | 2 |
| Sham Goel | Non-Executive - Independent Director | 2024-08-13 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal |
| Nomination and remuneration committee | Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal |
| Stakeholders Relationship Committee | Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal |
| Risk Management Committee | Sham Goel (Chairperson), Ramit Madan, Sanjay Bansal |
| Corporate Social Responsibility Committee | Suresh Kumar Singh (Chairperson), Sangeeta Bishnoi, Ashwani Kumar Sharma, Sham Goel |
Group Structure of Shivalik Rasayan Limited
Shivalik Rasayan Limited has 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Shivalik Rasayan Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Shivalik Rasayan Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2026 | Citi Bank N.A. | ₹15 Cr | Open |
| 17 Dec 2024 | Others | ₹20 Lakh | Open |
| 22 Jul 2024 | Hdfc Bank Limited | ₹20.91 Lakh | Open |
| 29 Dec 2023 | Others | ₹49 Cr | Open |
| 29 Sep 2023 | Idbi Bank Limited | ₹17.17 Lakh | Open |
Total charge records: 19 View all charges
Employees and EPFO Compliance at Shivalik Rasayan Limited
View historical data on people associated with Shivalik Rasayan Limited, including employment history and EPFO contributions.
Employee and EPFO history for Shivalik Rasayan Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Shivalik Rasayan Limited
GST registrations and filing compliance for Shivalik Rasayan Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Shivalik Rasayan Limited
Credit ratings, litigation, and regulatory alerts for Shivalik Rasayan Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Shivalik Rasayan Limited
MSME payment history for Shivalik Rasayan Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Shivalik Rasayan Limited
Corporate group structure for Shivalik Rasayan Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Shivalik Rasayan Limited
MCA filings and documents for Shivalik Rasayan Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Shivalik Rasayan Limited
Frequently Asked Questions about Shivalik Rasayan Limited
Shivalik Rasayan Limited is an active public limited company in the agriculture sector based in Dehradun, Uttarakhand, India. It was incorporated on 16 March 1979 (47+ years old) and is registered under CIN L24237UR1979PLC005041. Listed on BSE: 539148 and NSE: SHIVALIK.
Shivalik Rasayan Limited reported revenue of ₹368 Cr for FY 2026 (up 18.04% YoY) based on consolidated NSE filings.
The current directors of Shivalik Rasayan Limited are:
- Sangeeta Bishnoi - Director
- Sumita Dwivedi - Director
- Ravi Kumar Bansal - Director
- Rahul Bishnoi - Director
- Ashwani Kumar Sharma - Director
- Vimal Kumar Shrawat - Managing Director
- Suresh Kumar Singh - Whole-Time Director
- Shaival Saurabh - Director
- Sham Goel - Director
- Ramit Madan - Director
The primary industry of Shivalik Rasayan Limited is agriculture. The company specifically operates in crop protection. The company is currently active in this sector.
Yes. Shivalik Rasayan Limited is listed on both BSE (code: 539148) and NSE (symbol: SHIVALIK).
Shivalik Rasayan Limited can be reached at the registered office: Village Kolhupani Post Office Chandanwari Via Prem Nagar, Dehradun, Uttarakhand, India – 248007, or through the website shivalikrasayan.com.